Side by Side In 2013 the U S Food and Drug Administration

Last updated: 9/20/2023

Side by Side In 2013 the U S Food and Drug Administration FDA made an announcement regarding widely used sleep drugs containing the active ingredient zolpidem It contained the statement Since women eliminate zolpidem from their bodies more slowly than men the FDA has notified the manufacturers that the recommended dose should be lowered for women 1 U S Food and Drug Administration FDA FDA requiring lower recommended dose for certain sleep drugs containing zolpidem January 10 2013 www fda gov News Events Newsroom Press Announcements ucm334798 ht m Macmillan Learning A lurking variable was later revealed leading the to issue a notification What is this lurking variabl blood type level of insomnia drug safety gender What is the reason cited explaining the impact of lurking variable The FDA is recalling the drug zolpidem O The FDA cited that women eliminate zolpid from their bodies more slowly than men O The FDA cited that women eliminate zolpid from their bodies more quickly than men O The FDA cited that men eliminate zolpidem their bodies more slowly than women